Workflow
X
icon
搜索文档
Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million
Globenewswire· 2025-07-25 23:00
文章核心观点 临床阶段生物技术公司Inmagene与Ikena Oncology完成合并 成立ImageneBio公司 并将推进IMG - 007的后期开发 [1][3] 公司合并信息 - 临床阶段生物技术公司Inmagene与Ikena Oncology完成合并 合并后公司名为ImageneBio 于2025年7月28日周一开盘在纳斯达克以代码“IMA”开始交易 [1] - 合并同时 Inmagene和Ikena与包括Deep Track Capital等在内的现有和新投资者完成7500万美元私募融资 [2] - 合并公司将由Kristin Yarema博士担任首席执行官 [2] - Ikena实施1比12的普通股反向拆分 合并完成后 Inmagene原股权持有人拥有合并公司约55.0%的已发行普通股 Ikena原股权持有人拥有约45.0% 私募融资完成后 Inmagene原股权持有人拥有约43.1% Ikena原股权持有人拥有约35.3% 私募融资投资者拥有约21.6% 合并后ImageneBio约有1160万股普通股流通 [4] 公司业务信息 - ImageneBio是临床阶段生物技术公司 致力于开发免疫/自身免疫和炎症性疾病的新药 其主要资产IMG - 007已完成特应性皮炎和斑秃的2a期临床试验 目前正在进行中度至重度特应性皮炎的2b期临床试验 预计2026年第四季度公布2b期顶线数据 [1][6] - IMG - 007是一种靶向OX40的非耗竭性单克隆抗体 可避免T细胞耗竭或杀伤 延长半衰期 2a期试验中表现出持续的临床和药效学活性且耐受性良好 [7] 公司顾问信息 - Goodwin Procter LLP担任Ikena法律顾问 Cooley LLP担任Inmagene法律顾问 [5] - Leerink Partners LLC担任Ikena独家财务顾问 Evercore担任Inmagene独家财务顾问 [5] 公司联系方式 - 联系人Anna Vardanyan 邮箱vardanyana@inmagenebio.com [12] - 联系人Brian Ritchie 邮箱britchie@lifesciadvisors.com [12]
Virtus Investment Partners(VRTS) - 2025 Q2 - Earnings Call Transcript
2025-07-25 23:00
Virtus Investment Partners (VRTS) Q2 2025 Earnings Call July 25, 2025 10:00 AM ET Speaker0Good morning. My name is Pheedi, and I will be your conference operator today. I would like to welcome everyone to the Virtus Investment Partners Quarterly Conference Call. The slide presentation for this call is available in the Investor Relations section of the Virtus website, www.virtus.com. This call is being recorded and will be available for replay on the Virtus website.At this time, all participants are in a lis ...
Buenaventura(BVN) - 2025 Q2 - Earnings Call Presentation
2025-07-25 23:00
Note: (1) Consolidated figures includes 100% BVN, 100% La Zanja and 100% El Brocal. (2) Net Income attributable to owners of the parent. 3 2Q25 Earnings Results Conference Call Cautionary Statement This presentation contains certain information that may constitute forward-looking information under applicable U.S. securities legislation, including but not limited to information about costs applicable to sales, general and administrative expenses; production volumes; current expectations on the timing, extent ...
Portland General Electric(POR) - 2025 Q2 - Earnings Call Presentation
2025-07-25 23:00
Investor Presentation PORTLAND GENERAL ELECTRIC July 25, 2025 Cautionary statement Portland General Electric investors.portlandgeneral.com 121 SW Salmon Street Suite 1WTC0506 Portland, OR 97204 Nick White (503) 464-8073 Nicholas.White@pgn.com Sydnie Hinds (503) 464-7111 Sydnie.Hinds@pgn.com Information Current as of July 25, 2025 Except as expressly noted, the information in this presentation is current as of July 25, 2025 – the date on which PGE filed its Quarterly Report on Form 10-Q for the quarter ended ...
EQNR's US Wind Projects Incur $955M Impairment Over Regulatory Changes
ZACKS· 2025-07-25 22:42
Key Takeaways Equinor reported $955M in impairments tied to U.S. offshore wind projects in Q2 earnings.Policy shifts, rising costs, and reduced incentives hurt Empire Wind and South Brooklyn asset values.$763M of impairments stem from Empire Wind 1 and South Brooklyn; Phase 2 may not proceed without tax credits.Equinor ASA (EQNR) , a Norwegian integrated energy company, stated that it has incurred impairment costs of $955 million associated with its U.S. offshore wind projects. During its second-quarter ear ...
Down 14.3% in 4 Weeks, Here's Why Palomar (PLMR) Looks Ripe for a Turnaround
ZACKS· 2025-07-25 22:35
Palomar (PLMR) has been beaten down lately with too much selling pressure. While the stock has lost 14.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price m ...
After Plunging 14.4% in 4 Weeks, Here's Why the Trend Might Reverse for Iridium (IRDM)
ZACKS· 2025-07-25 22:35
Iridium Communications (IRDM) has been beaten down lately with too much selling pressure. While the stock has lost 14.4% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and ch ...
Royal Gold (RGLD) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-07-25 22:35
A downtrend has been apparent in Royal Gold (RGLD) lately with too much selling pressure. The stock has declined 13.6% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. T ...